26 Aug 2013, BioSpectrum Bureau , BioSpectrum
Singapore: US-based MediPurpose, a master distributor and manufacturer of medical products, has announced an addition to its expanding portfolio of lancet patents.
The medical product company recently received approval of patent EP2303123 ("A Device for Performing an Incision") for its babyLance(tm) safety heelstick from the European Patent Office (EPO) in Berlin, Germany.
BabyLance safety heelsticks are single-use safety needlestick devices for the collection of blood from infants.
Along with medical device patents in Singapore and Japan for babyLance, MediPurpose also holds EPO medical device patents for its popular SurgiLance(tm) safety lancet.